The L Protein of Rift Valley Fever Virus Can Rescue Viral Ribonucleoproteins and Transcribe Synthetic Genome-like RNA Molecules
Overview
Affiliations
Overlapping cDNAs representing the complete L segment of Rift Valley fever virus were assembled, and the L protein was expressed via a recombinant vaccinia virus. The transcriptase activity of the L protein was assayed with two types of templates: natural ribonucleoproteins (RNPs) and artificial genome-like RNAs. RNPs purified in a CsCl gradient did not retain the RNA polymerase function, but the activity was restored when the L cDNA was expressed in mammalian cells via a recombinant vaccinia virus. Indeed, after transfection of transcriptase-depleted RNPs in cells infected with the recombinant vaccinia virus expressing the L protein, the mRNAs coding for the N and NSs proteins and to a lesser extent, those coding for the glycoproteins were synthesized as well as the corresponding proteins. The transcriptase activity of the recombinant L protein was then investigated by using synthetic templates containing the reporter chloramphenicol acetyltransferase gene in the antisense orientation flanked by the 3' and 5' noncoding region of the S genomic segment. Our results indicate that after transfection of the RNA templates, transcription was achieved in cells coexpressing both the L and N proteins. Together, the experiments demonstrate that the two proteins N and L are absolutely required and sufficient to reconstitute the transcriptase activity.
Comparative study of two Rift Valley fever virus field strains originating from Mauritania.
Chabert M, Lacote S, Marianneau P, Confort M, Aurine N, Pedarrieu A PLoS Negl Trop Dis. 2024; 18(12):e0012728.
PMID: 39652604 PMC: 11658707. DOI: 10.1371/journal.pntd.0012728.
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques.
Bian T, Hao M, Zhao X, Zhao C, Luo G, Zhang Z NPJ Vaccines. 2023; 8(1):164.
PMID: 37891181 PMC: 10611786. DOI: 10.1038/s41541-023-00763-2.
Host entry factors of Rift Valley Fever Virus infection.
Ganaie S, Leung D, Hartman A, Amarasinghe G Adv Virus Res. 2023; 117():121-136.
PMID: 37832991 PMC: 11312830. DOI: 10.1016/bs.aivir.2023.09.001.
Hamele C, Spurrier M, Leonard R, Heaton N Annu Rev Virol. 2023; 10(1):261-282.
PMID: 37774125 PMC: 10795101. DOI: 10.1146/annurev-virology-111821-120445.
Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
Xu L, Paine A, Barbeau D, Alencastro F, Duncan A, McElroy A J Virol. 2023; 97(9):e0085323.
PMID: 37695055 PMC: 10537571. DOI: 10.1128/jvi.00853-23.